BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23299156)

  • 21. Real-time quantification for BCR-ABL transcripts in chronic myeloid leukaemia patients in UKMMC, Malaysia.
    Wong FL; Hamidah NH; Hawa AA; Nurul AN; Leong CF; Saw F; Ainoon O
    Malays J Pathol; 2011 Dec; 33(2):107-12. PubMed ID: 22299211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis.
    Saglio G; Pane F; Gottardi E; Frigeri F; Buonaiuto MR; Guerrasio A; de Micheli D; Parziale A; Fornaci MN; Martinelli G; Salvatore F
    Blood; 1996 Feb; 87(3):1075-80. PubMed ID: 8562932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid quantitative detection of BCR-ABL transcripts in chronic myeloid leukemia patients by real-time reverse transcriptase polymerase-chain reaction using fluorescently labeled probes.
    Bolufer P; Sanz GF; Barragán E; Sanz MA; Cervera J; Lerma E; Senent L; Moreno I; Planelles MD
    Haematologica; 2000 Dec; 85(12):1248-54. PubMed ID: 11114130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].
    Xing W; Gu BW; Zhu YM; Jiang CL; Zhao RH; Wang AH; Sun HP; Li JM; Shen ZX; Chen Z; Chen SJ
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):453-7. PubMed ID: 15854550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia.
    Adler R; Viehmann S; Kuhlisch E; Martiniak Y; Röttgers S; Harbott J; Suttorp M
    Eur J Haematol; 2009 Feb; 82(2):112-8. PubMed ID: 19067742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: the risk in misinterpreting negative results.
    Melo JV; Yan XH; Diamond J; Lin F; Cross NC; Goldman JM
    Leukemia; 1996 Jul; 10(7):1217-21. PubMed ID: 8684005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
    Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir.
    Azad NA; Shah ZA; Pandith AA; Khan MS; Rasool R; Rasool J; Aziz SA
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1479-1485. PubMed ID: 29936718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].
    Link-Lenczowska D; Sacha T; Zawada M; Czekalska S; Florek I; Skotnicki AB
    Przegl Lek; 2014; 71(5):258-62. PubMed ID: 25248240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCR-ABL Gene Transcript Types of Patients with Chronic Myelogenous Leukemia in Yogyakarta, Indonesia.
    Paramita DK; Hutajulu SH; Syifarahmah A; Sholika TA; Fatmawati S; Aning S; Sulistyawati D; Wahyuni S; Taroeno-Hariadi KW; Kurnianda J
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1545-1550. PubMed ID: 32592347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib.
    Agirre X; Román-Gómez J; Vázquez I; Jiménez-Velasco A; Larráyoz MJ; Lahortiga I; Andreu EJ; Márquez J; Beltrán de Heredia JM; Odero MD; Prósper F; Calasanz MJ
    Cancer Genet Cytogenet; 2005 Jul; 160(1):22-6. PubMed ID: 15949566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India.
    Anand MS; Varma N; Varma S; Rana KS; Malhotra P
    Indian J Med Res; 2012; 135(1):42-8. PubMed ID: 22382182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplex RT-PCR for the detection of common BCR-ABL fusion transcripts in paraffin-embedded tissues from patients with chronic myeloid leukemia and acute lymphoblastic leukemia.
    Bock O; Reising D; Kreipe H
    Diagn Mol Pathol; 2003 Sep; 12(3):119-23. PubMed ID: 12960692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LightCycler technology for the quantitation of bcr/abl fusion transcripts.
    Kreuzer KA; Lass U; Bohn A; Landt O; Schmidt CA
    Cancer Res; 1999 Jul; 59(13):3171-4. PubMed ID: 10397261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TaqMan RT-PCR assay coupled with capillary electrophoresis for quantification and identification of bcr-abl transcript type.
    Luthra R; Sanchez-Vega B; Medeiros LJ
    Mod Pathol; 2004 Jan; 17(1):96-103. PubMed ID: 14657955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis.
    Romero-Morelos P; González-Yebra AL; Muñoz-López D; Lara-Lona E; González-Yebra B
    Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of co-expressing M-bcr/abl and m-bcr/abl fusion gene transcripts on the clinical features of patients with chronic myelogenous leukemia at diagnosis].
    Meng WT; Liu T; Li JJ; Shi Q; Yu J; Cui X; Wu Y; Xiang B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):97-100. PubMed ID: 16468653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease.
    Bose S; Deininger M; Gora-Tybor J; Goldman JM; Melo JV
    Blood; 1998 Nov; 92(9):3362-7. PubMed ID: 9787174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual transcription of b2a2 and b3a2 BCR-ABL transcripts in chronic myeloid leukaemia is confined to patients with a linked polymorphism within the BCR gene.
    Branford S; Hughes TP; Rudzki Z
    Br J Haematol; 2002 Jun; 117(4):875-7. PubMed ID: 12060123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.